Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.
2.

Olanzapine: an updated review of its use in the management of schizophrenia.

Bhana N, Foster RH, Olney R, Plosker GL.

Drugs. 2001;61(1):111-61. Review.

PMID:
11217867
3.

Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.

Lako IM, van den Heuvel ER, Knegtering H, Bruggeman R, Taxis K.

J Clin Psychopharmacol. 2013 Oct;33(5):675-81. doi: 10.1097/JCP.0b013e3182983ffa. Review.

PMID:
23948784
4.
5.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
6.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
7.

Mechanism of new antipsychotic medications: occupancy is not just antagonism.

Grunder G, Carlsson A, Wong DF.

Arch Gen Psychiatry. 2003 Oct;60(10):974-7. Review.

PMID:
14557141
8.

Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications.

de Haan L, Lavalaye J, van Bruggen M, van Nimwegen L, Booij J, van Amelsvoort T, Linszen D.

Can J Psychiatry. 2004 May;49(5):290-6. Review.

PMID:
15198464
9.

Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia.

Kando JC, Shepski JC, Satterlee W, Patel JK, Reams SG, Green AI.

Ann Pharmacother. 1997 Nov;31(11):1325-34. Review.

PMID:
9391688
10.

Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench.

Kapur S, Wadenberg ML, Remington G.

Can J Psychiatry. 2000 Apr;45(3):241-6. Review.

PMID:
10779880
12.
13.

Olanzapine: a systematic review and meta-regression of the relationships between dose, plasma concentration, receptor occupancy, and response.

Bishara D, Olofinjana O, Sparshatt A, Kapur S, Taylor D, Patel MX.

J Clin Psychopharmacol. 2013 Jun;33(3):329-35. doi: 10.1097/JCP.0b013e31828b28d5. Review.

PMID:
23609380
14.
15.

Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis.

Uchida H, Takeuchi H, Graff-Guerrero A, Suzuki T, Watanabe K, Mamo DC.

J Clin Psychopharmacol. 2011 Aug;31(4):497-502. doi: 10.1097/JCP.0b013e3182214aad. Review.

PMID:
21694629
16.

Management of symptoms associated with advanced cancer: olanzapine and mirtazapine. A World Health Organization project.

Davis MP, Khawam E, Pozuelo L, Lagman R.

Expert Rev Anticancer Ther. 2002 Aug;2(4):365-76. Review.

PMID:
12647979

Supplemental Content

Support Center